C
Christopher M. Jones
Researcher at Centers for Disease Control and Prevention
Publications - 123
Citations - 11267
Christopher M. Jones is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Medical prescription & Poison control. The author has an hindex of 43, co-authored 112 publications receiving 8025 citations. Previous affiliations of Christopher M. Jones include Washington University in St. Louis & United States Public Health Service.
Papers
More filters
Journal ArticleDOI
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use
TL;DR: A large fraction of heroin users now report that they formerly used prescription opioids nonmedically, a finding that has led to restrictions on opioid prescribing, but only a small fraction of prescription-opioid users move on to heroin use.
Journal ArticleDOI
Prescription Opioid Use, Misuse, and Use Disorders in U.S. Adults: 2015 National Survey on Drug Use and Health
TL;DR: The 12-month prevalence of prescription opioid use by sociodemographic characteristics, health conditions, and behavioral health status; the prevalence of misuse and use disorders among prescription opioid users; motivations for misuse; and sources of prescription opioids among adults with misuse andUse disorders are examined.
Journal ArticleDOI
Pharmaceutical Overdose Deaths, United States, 2010
TL;DR: Although it is debated as to whether early diagnosis of COPD is useful, COPD and emphysema are independent predictors of lung cancer; therefore, detection may aid a more personalized and cost-effective lung cancer screening regimen.
Journal ArticleDOI
Trends in Opioid Analgesic–Prescribing Rates by Specialty, U.S., 2007–2012
TL;DR: The data indicate diverging trends in opioid prescribing among medical specialties in the U.S. during 2007-2012, which is critical for continued improvement in the safe and effective treatment of pain.
Journal ArticleDOI
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
TL;DR: Significant gaps between treatment need and capacity exist at the state and national levels and strategies to increase the number of OA-MAT providers are needed.